Reports Q1 revenue $1.14B, consensus $1.15B. “Our core business is performing well, and we remain focused on positioning the company for long-term, profitable growth,” said Brent Saunders, chairman and CEO, Bausch + Lomb (BLCO). “We’re making meaningful progress in our journey to significantly enhance the standard of care in eye health, which motivates us every day.”
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BLCO:
- Cautious Outlook on Bausch + Lomb Amid enVista Relaunch and Tariff Challenges
- Bausch + Lomb Resumes enVista Lens Production After Safety Recall
- Bausch + Lomb price target lowered to $17 from $18 at RBC Capital
- Bausch + Lomb price target lowered to $15 from $17 at Stifel
- Bausch + Lomb Faces Growth Challenges Amid enVista Lens Recall and Increased Competition